Last Close
Apr 09  •  04:00PM ET
4.62
Dollar change
-0.04
Percentage change
-0.86
%
Index
RUT
P/E
-
EPS (ttm)
-0.52
Insider Own
9.32%
Shs Outstand
128.55M
Perf Week
3.12%
Market Cap
593.90M
Forward P/E
-
EPS next Y
-0.14
Insider Trans
0.00%
Shs Float
116.57M
Perf Month
9.22%
Enterprise Value
365.39M
PEG
-
EPS next Q
-0.10
Inst Own
63.98%
Perf Quarter
-16.00%
Income
-66.54M
P/S
2.95
EPS this Y
59.62%
Inst Trans
1.45%
Perf Half Y
21.90%
Sales
201.49M
P/B
1.74
EPS next Y
31.43%
ROA
-13.81%
Perf YTD
-8.51%
Book/sh
2.66
P/C
2.27
EPS next 5Y
55.23%
ROE
-18.05%
52W High
6.18 -25.24%
Perf Year
23.53%
Cash/sh
2.03
P/FCF
-
EPS past 3/5Y
- -
ROIC
-18.33%
52W Low
2.37 94.94%
Perf 3Y
-48.55%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
7.10% 16.76%
Gross Margin
51.84%
Volatility
4.70% 4.36%
Perf 5Y
-
Dividend TTM
-
EV/Sales
1.81
EPS Y/Y TTM
-1062.64%
Oper. Margin
-20.04%
ATR (14)
0.21
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
4.42
Sales Y/Y TTM
0.52%
Profit Margin
-33.02%
RSI (14)
56.58
Dividend Gr. 3/5Y
- -
Current Ratio
5.04
EPS Q/Q
-560.99%
SMA20
4.24%
Beta
1.29
Payout
-
Debt/Eq
0.10
Sales Q/Q
8.12%
SMA50
3.49%
Rel Volume
0.56
Prev Close
4.66
Employees
700
LT Debt/Eq
0.06
SMA200
6.22%
Avg Volume
801.87K
Price
4.62
IPO
Jul 23, 2021
Option/Short
Yes / Yes
Trades
Volume
451,495
Change
-0.86%
Date Action Analyst Rating Change Price Target Change
Dec-02-25Resumed Morgan Stanley Equal-Weight $6
May-09-25Downgrade TD Cowen Buy → Hold $4
Jan-31-25Downgrade Goldman Buy → Sell $7 → $4.50
Dec-14-23Initiated Stephens Overweight $9
Jul-19-23Initiated Raymond James Mkt Perform
Jan-06-22Resumed Piper Sandler Overweight $20
Mar-09-26 05:00PM
02:04AM
Feb-27-26 08:30AM
12:04AM
Feb-26-26 10:07PM
08:05PM Loading…
08:05PM
04:05PM
Feb-18-26 04:05PM
Feb-12-26 04:05PM
Jan-12-26 05:21AM
05:00AM
Nov-12-25 05:00PM
Nov-06-25 05:00PM
04:05PM
12:06AM
07:10PM Loading…
Nov-05-25 07:10PM
04:05PM
Nov-04-25 08:24AM
Oct-29-25 05:00PM
Oct-22-25 04:05PM
Oct-15-25 05:00PM
Sep-24-25 03:42AM
Sep-10-25 05:00PM
Aug-12-25 04:05PM
Aug-06-25 08:20PM
04:05PM
Aug-05-25 10:16AM
Jul-24-25 08:55AM
Jul-23-25 04:05PM
Jul-03-25 01:00PM
11:38PM Loading…
May-29-25 11:38PM
05:00PM
May-28-25 04:05PM
May-09-25 03:44AM
May-08-25 06:10PM
04:05PM
May-07-25 05:35PM
10:53AM
May-05-25 08:14AM
Apr-29-25 05:00PM
Apr-28-25 08:15AM
Apr-24-25 04:05PM
Mar-18-25 05:00PM
Mar-08-25 06:43AM
Feb-28-25 02:38AM
Feb-27-25 06:15PM
04:05PM
Feb-26-25 08:00AM
Feb-13-25 04:05PM
Feb-05-25 04:05PM
Jan-15-25 08:00AM
Jan-02-25 08:00AM
Dec-30-24 08:00AM
Nov-20-24 04:05PM
Nov-19-24 05:00PM
Nov-07-24 05:00PM
Nov-06-24 04:00AM
Nov-05-24 05:15PM
04:05PM
Nov-04-24 07:10AM
Oct-30-24 04:05PM
Oct-29-24 04:05PM
Sep-18-24 05:00PM
Sep-12-24 03:20PM
Aug-21-24 05:00PM
Aug-08-24 04:05PM
Aug-06-24 06:20PM
04:05PM
Jul-30-24 05:00PM
04:05PM
Jun-24-24 08:31AM
Jun-06-24 08:00AM
May-30-24 04:05PM
May-28-24 05:30PM
May-20-24 05:30PM
May-13-24 09:41AM
09:37AM
May-10-24 02:18PM
May-09-24 03:44AM
May-08-24 10:58PM
07:30PM
04:05PM
Apr-30-24 05:45PM
05:30PM
Apr-29-24 09:00AM
Apr-26-24 09:30AM
Apr-11-24 09:35AM
Apr-10-24 09:55AM
Mar-27-24 11:53AM
Mar-20-24 01:50AM
Mar-19-24 08:00AM
Mar-07-24 05:30PM
Mar-01-24 06:31AM
Feb-29-24 10:26AM
Feb-28-24 05:05PM
Feb-21-24 10:00AM
Feb-07-24 04:10PM
04:05PM
Jan-17-24 05:30PM
Jan-09-24 05:56AM
Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. Its products include Cytek Aurora CS, Cytek Aurora, Cytek Northern Lights, and Cytek NL-CLC. The company was founded by Wenbin Jiang and Ming Yan in 1992 and is headquartered in Fremont, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Holder MichaelDirectorAug 18 '25Option Exercise0.002,181010,178Aug 20 05:43 PM
McCombe William D.Chief Financial OfficerJun 02 '25Buy2.7835,00097,30055,746Jun 03 05:39 PM